IM Cannabis (IMCC) Cash from Investing Activities (2020 - 2026)
IM Cannabis' (IMCC) quarterly Cash from Investing Activities came in at $312829.2 in Q1 2026, up 127.11% quarter-over-quarter from -$1.2 million in Q4 2025.
IM Cannabis (IMCC) Cash from Investing Activities (2020 - 2026) Analysis & Trends
IM Cannabis' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $312829.2 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to $312829.2 in Q1 2026; TTM through Mar 2026 was -$70024.4, a N/A change from a year earlier, with the FY2025 full-year figure at -$380772.8, down 10.92% from the prior year.
- Cash from Investing Activities rose to $312829.2 in Q1 2026 per IMCC's latest filing, from -$1.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $1.1 million in Q3 2022 and bottomed at -$1.7 million in Q4 2022.
- The 5-year median for Cash from Investing Activities is -$147519.3 (2022), against an average of -$172047.6.
- Biggest YoY gain for Cash from Investing Activities was 1518.55% in 2025; the steepest drop was 80689.04% in 2025.
- Year by year, Cash from Investing Activities stood at -$1.7 million in 2022, then surged by 73.41% to -$462022.8 in 2023, then surged by 100.31% to $1431.7 in 2024, then tumbled by 80689.04% to -$1.2 million in 2025, then soared by 127.11% to $312829.2 in 2026.
- Per Business Quant, the three latest IMCC Cash from Investing Activities figures stand at $312829.2 (Q1 2026), -$1.2 million (Q4 2025), and $769506.5 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.63 Bn | 30.69 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | -60.00 Mn |
| 10 | IM Cannabis | 525,798.39 | -206,324.13 | 1.03 Mn | 312,829.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 312,829.24 |
| Mar 31, 2026 | 312,829.24 |
| Dec 31, 2025 | -1.15 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Sep 30, 2025 | 769,506.47 |
| Sep 30, 2025 | 769,506.47 |
| Dec 31, 2024 | 1,431.70 |
| Dec 31, 2024 | 1,431.70 |
| Sep 30, 2024 | -54,245.95 |
| Sep 30, 2024 | -54,245.95 |
| Jun 30, 2024 | -292,456.22 |
| Jun 30, 2024 | -292,456.22 |
| Mar 31, 2024 | 1,484.23 |
| Mar 31, 2024 | 1,484.23 |
| Dec 31, 2023 | -462,022.85 |
| Dec 31, 2023 | -462,022.85 |
| Jun 30, 2023 | -759,341.51 |
| Jun 30, 2023 | -759,341.51 |
| Mar 31, 2023 | 345,438.20 |
| Mar 31, 2023 | 345,438.20 |